SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-060453
Filing Date
2024-05-15
Accepted
2024-05-15 16:10:16
Documents
13
Period of Report
2024-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bior-20240515.htm   iXBRL 8-K 44751
2 EX-99.1 bior-ex99_1.htm EX-99.1 221257
3 GRAPHIC img208566971_0.jpg GRAPHIC 15252
  Complete submission text file 0000950170-24-060453.txt   426565

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bior-20240515.xsd EX-101.SCH 31516
16 EXTRACTED XBRL INSTANCE DOCUMENT bior-20240515_htm.xml XML 4898
Mailing Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122
Business Address 4330 LA JOLLA VILLAGE DRIVE SUITE 200 SAN DIEGO CA 92122 855-293-2639
BIORA THERAPEUTICS, INC. (Filer) CIK: 0001580063 (see all company filings)

IRS No.: 273950390 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39334 | Film No.: 24950667
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)